(The chief science officer at the FDAs Center for Tobacco Products, who played an important role in that decision, resigned a few years later to take a job at Philip Morris.) In 2020, the FDA allowed Philip Morris to market IQOS as a reduced-exposure product meaning that it could claim that switching from cigarettes to IQOS would lessen peoples exposure to harmful chemicals because the devices heat, rather than burn, tobacco
www.adm.gov.it
However, as awareness about smoking-related health issues grew, so did concerns among the Canadian population
October 4, 2023
Contrib Tob Res 20:2341 Bell ML, Ebisu K, Peng RD, Walker J, Samet JM, Zeger SL, Dominici F (2008) Seasonal and regional short-term effects of fine particles on hospital admissions in 202 US counties, 19992005
Protocol for the process evaluation of an intervention to improve antenatal smoking cessation support (MOHMQuit) in maternity services in New South Wales, Australia Jo Longman, Christine Paul, Aaron Cashmore, Laura Twyman, Larisa A J Barnes, Catherine Adams, Billie Bonevski, Andrew Milat, Megan E Passey BMJ Open 45